Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The Viral Inactivation Market Size?
The market size for viral inactivation has seen substantial expansion in the last few years. The market is expected to grow from $5.01 billion in 2024 to $5.47 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.2%. The surge in growth during the historic period can be credited to worldwide growth in air traffic, upgraded navigation capabilities, increased commercial aviation, savings in airline costs, enhanced flight safety, and decreased burden on pilots.
The market size of viral inactivation is projected to experience swift expansion in the upcoming years. The market is forecasted to reach $8.24 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.8%. The predicted growth in this timeframe is largely due to the progression of autonomous flights, innovative aircraft designs, the push for eco-friendly aviation, urban air mobility (uam), and an escalating demand for aircraft. Trends that are anticipated to dominate this forecasted period include the adoption of cutting-edge avionics, the application of artificial intelligence, advancements in the human-machine interface (hmi), renovation of existing aircraft, and the incorporation of the global navigation satellite system (gnss).
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp
Which Demand Drivers Are Strengthening The Viral Inactivation Market?
The viral inactivation market is projected to expand due to the rising occurrences of various contagious ailments. Such illnesses, which include air and foodborne conditions caused by viruses, bacteria, fungi, and parasites, can be passed from one person to another. The use of viral inactivation techniques, involving physical and chemical disinfectants, is widespread in human disease control to mitigate the dissemination of viral contagions, thereby boosting the growth of the viral inactivation market. For exemplification, the Centers for Disease Control and Prevention, a US national public health institution, reported in March 2024 that tuberculosis cases surged from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. The frequency similarly ascended from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Consequently, the ascending prevalence of numerous infectious ailments is stimulating the expansion of the viral inactivation market.
What Segmentation Insights Are Provided In The Viral Inactivation Market Research?
The viral inactivationmarket covered in this report is segmented –
1) By Product: Kits And Reagents; Systems; Services
2) By Method: Solvent Detergent Method; pH Adjustment Method; Pasteurization; Other Methods
3) By Application: Vaccines And Therapeutics; Tissues And Tissue Products; Blood And Blood Products; Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Blood Banks; Hospital; Academic Research Institutes; Other End Users
Subsegments:
1) By Kits And Reagents: Viral Inactivation Kits; PCR Reagents; Antibodies and Enzymes
2) By Systems: Automated Viral Inactivation Systems; Batch Viral Inactivation Systems; Continuous Flow Systems
3) By Services: Viral Testing Services; Validation Services; Consulting Services
Which Trends Are Likely To Redefine Growth Paths In The Viral Inactivation Market?
A primary trend emerging in the viral inactivation market is the escalating adoption of sophisticated technological processes. To maintain their market standing, entities active in this domain are embracing avant-garde technological methods. A prime illustration of this trend occurred in March 2022, when WuXi Advanced Therapies, an entirely owned subsidiary of WuXi AppTec, a biopharmaceutical company based in China, debuted their Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology. This ground-breaking technology has facilitated the sanctioning of new therapies by performing assay formulation, biosafety, viral clearance, product release, and testing concurrently and internally. This method presents an unprecedented innovative approach for producing adeno-associated virus (AAV) at Good Manufacturing Practices (GMP) grade, eliminating the need for transfection.
Which Firms Are Driving Innovation Within The Viral Inactivation Market?
Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report
Which Regional Markets Are Emerging As Key Hubs For The Viral Inactivation Market?
North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=10401&type=smp
Browse Through More Reports Similar to the Global Viral Inactivation Market 2025, By The Business Research Company
Viral Vectors And Plasmid Dna Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report
Antivirals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report
Healthcare Personal Protective Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model